These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19237211

  • 1. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
    Yamagishi S, Matsui T, Ueda S, Takeuchi M.
    Int J Cardiol; 2010 Oct 08; 144(2):283-5. PubMed ID: 19237211
    [Abstract] [Full Text] [Related]

  • 2. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H.
    Diabetes Metab Res Rev; 2009 Mar 08; 25(3):266-71. PubMed ID: 19165765
    [Abstract] [Full Text] [Related]

  • 3. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.
    Ophthalmic Res; 2007 Mar 08; 39(2):92-7. PubMed ID: 17284935
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T.
    Microvasc Res; 2006 Mar 08; 72(1-2):86-90. PubMed ID: 16797605
    [Abstract] [Full Text] [Related]

  • 5. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y, Matsui T, Ishibashi Y, Takeuchi M, Yamagishi S.
    Microvasc Res; 2010 Sep 08; 80(2):227-32. PubMed ID: 20381502
    [Abstract] [Full Text] [Related]

  • 6. Blockade by nifedipine of advanced glycation end product-induced CD40-CD40 ligand interaction in endothelial cells.
    Yamagishi S, Kikuchi S, Takenaka K, Takeuchi M.
    Drugs Exp Clin Res; 2005 Sep 08; 31(5-6):221-6. PubMed ID: 16425979
    [Abstract] [Full Text] [Related]

  • 7. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
    Yamagishi S, Matsui T, Inoue H.
    Drugs Exp Clin Res; 2005 Sep 08; 31(5-6):227-32. PubMed ID: 16425980
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.
    Am J Physiol Renal Physiol; 2008 May 08; 294(5):F1166-73. PubMed ID: 18322021
    [Abstract] [Full Text] [Related]

  • 9. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 08; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levels.
    Yamagishi S, Matsui T, Nakamura K, Takenaka K.
    Int J Cardiol; 2010 Apr 01; 140(1):121-2. PubMed ID: 19046781
    [Abstract] [Full Text] [Related]

  • 11. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation.
    Ishibashi Y, Matsui T, Ohta K, Tanoue R, Takeuchi M, Asanuma K, Fukami K, Okuda S, Nakamura K, Yamagishi S.
    Microvasc Res; 2013 Jan 01; 85():54-8. PubMed ID: 23108227
    [Abstract] [Full Text] [Related]

  • 12. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
    Maeda S, Matsui T, Takeuchi M, Yoshida Y, Yamakawa R, Fukami K, Yamagishi S.
    Pharmacol Res; 2011 Mar 01; 63(3):241-8. PubMed ID: 21115116
    [Abstract] [Full Text] [Related]

  • 13. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
    Takenaka K, Yamagishi S, Matsui T, Nakamura K, Jinnouchi Y, Yoshida Y, Ueda S, Katsuki Y, Katsuda Y, Imaizumi T.
    Atherosclerosis; 2008 Mar 01; 197(1):25-33. PubMed ID: 17850801
    [Abstract] [Full Text] [Related]

  • 14. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S.
    Biochimie; 2010 Aug 01; 92(8):1040-51. PubMed ID: 20470857
    [Abstract] [Full Text] [Related]

  • 15. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Yokoi M, Yamagishi S, Saito A, Yoshida Y, Matsui T, Saito W, Hirose S, Ohgami K, Kase M, Ohno S.
    Br J Ophthalmol; 2007 Jul 01; 91(7):885-7. PubMed ID: 17301120
    [Abstract] [Full Text] [Related]

  • 16. Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B.
    Yamagishi S, Nakamura K, Takenaka K, Matsui T, Jinnouchi Y, Imaizumi T.
    Microvasc Res; 2005 May 01; 69(3):128-34. PubMed ID: 15896354
    [Abstract] [Full Text] [Related]

  • 17. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T.
    Cell Tissue Res; 2005 Jun 01; 320(3):437-45. PubMed ID: 15846509
    [Abstract] [Full Text] [Related]

  • 18. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
    Amano S, Yamagishi S, Inagaki Y, Nakamura K, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2005 Jan 01; 69(1-2):45-55. PubMed ID: 15797260
    [Abstract] [Full Text] [Related]

  • 19. Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation.
    Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Ueno T, Sata M.
    FEBS Lett; 2006 May 15; 580(11):2788-96. PubMed ID: 16674952
    [Abstract] [Full Text] [Related]

  • 20. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M, Ogata N, Minamino K, Higuchi A, Matsumura M.
    Exp Eye Res; 2006 Jan 15; 82(1):172-8. PubMed ID: 16054135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.